Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11226-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11226-1-AP, RRID:AB_2201665
- Product name
- TH1L antibody
- Antibody type
- Polyclonal
- Description
- TH1L antibody (Cat. #11226-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages.
CRL3(ARMC5) ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription.
Strength of T cell signaling regulates HIV-1 replication and establishment of latency.
RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.
Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.
Lu J, Meng J, Wu G, Wei W, Xie H, Liu Y
Molecular medicine (Cambridge, Mass.) 2024 Jul 30;30(1):110
Molecular medicine (Cambridge, Mass.) 2024 Jul 30;30(1):110
CRL3(ARMC5) ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription.
Cacioppo R, Gillis A, Shlamovitz I, Zeller A, Castiblanco D, Crisp A, Haworth B, Arabiotorre A, Abyaneh P, Bao Y, Sale JE, Berry S, Tufegdžić Vidaković A
Molecular cell 2024 Dec 19;84(24):4808-4823.e13
Molecular cell 2024 Dec 19;84(24):4808-4823.e13
Strength of T cell signaling regulates HIV-1 replication and establishment of latency.
Gagne M, Michaels D, Schiralli Lester GM, Gummuluru S, Wong WW, Henderson AJ
PLoS pathogens 2019 May;15(5):e1007802
PLoS pathogens 2019 May;15(5):e1007802
RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.
Kaczmarek Michaels K, Wolschendorf F, Schiralli Lester GM, Natarajan M, Kutsch O, Henderson AJ
Virology 2015 Dec;486:7-14
Virology 2015 Dec;486:7-14
Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.
Natarajan M, Schiralli Lester GM, Lee C, Missra A, Wasserman GA, Steffen M, Gilmour DS, Henderson AJ
The Journal of biological chemistry 2013 Sep 6;288(36):25995-26003
The Journal of biological chemistry 2013 Sep 6;288(36):25995-26003
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The TH1L antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TH1L. This antibody recognizes human, mouse, rat antigen. The TH1L antibody has been validated for the following applications: ELISA, WB analysis.